Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126946201 | 12694620 | 1 | I | 20150412 | 20160519 | 20160829 | 20160829 | EXP | US-BAYER-2016-103680 | BAYER | 62.00 | YR | A | M | Y | 101.36000 | KG | 20160829 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126946201 | 12694620 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | ||||
| 126946201 | 12694620 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | Y | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | ||||
| 126946201 | 12694620 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Y | N | 0 | FILM-COATED TABLET | |||||||||
| 126946201 | 12694620 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Y | N | 0 | FILM-COATED TABLET | |||||||||
| 126946201 | 12694620 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Y | N | 0 | FILM-COATED TABLET | |||||||||
| 126946201 | 12694620 | 6 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | 81 MG, QD | 999999 | 81 | MG | TABLET | QD | ||||||
| 126946201 | 12694620 | 7 | SS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | 75 MG, QD | 0 | 75 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126946201 | 12694620 | 1 | Thrombosis prophylaxis |
| 126946201 | 12694620 | 2 | Deep vein thrombosis |
| 126946201 | 12694620 | 3 | Cerebrovascular accident prophylaxis |
| 126946201 | 12694620 | 4 | Atrial fibrillation |
| 126946201 | 12694620 | 5 | Embolism venous |
| 126946201 | 12694620 | 6 | Product used for unknown indication |
| 126946201 | 12694620 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126946201 | 12694620 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126946201 | 12694620 | Epistaxis | |
| 126946201 | 12694620 | Gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126946201 | 12694620 | 1 | 20150311 | 201506 | 0 | |
| 126946201 | 12694620 | 2 | 20150616 | 20150625 | 0 |